Analyze Diet

Topic:Gonadotropin-Releasing Hormone

Gonadotropin-Releasing Hormone (GnRH) is a neuropeptide hormone produced in the hypothalamus of horses. It is involved in the regulation of reproductive processes by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. These hormones are key regulators of gonadal function, influencing processes such as estrus, ovulation, and spermatogenesis. The study of GnRH in horses includes understanding its physiological roles, mechanisms of action, and its application in managing reproductive health. This page compiles peer-reviewed research studies and scholarly articles that explore the function, regulation, and clinical applications of Gonadotropin-Releasing Hormone in equine reproduction.
Serum anti-Müllerian hormone dynamics in mares following immunocontraception with anti-zona pellucida or -GnRH vaccines.
Theriogenology    October 5, 2017   Volume 106 214-220 doi: 10.1016/j.theriogenology.2017.10.004
Joonè CJ, Schulman ML, Fosgate GT, Claes ANJ, Gupta SK, Botha AE, Human A, Bertschinger HJ.Circulating anti-Müllerian hormone concentration (AMH) is positively correlated to the number of small growing follicles in the mare and may reflect ovarian function. Dynamics of AMH during immunocontraception have not previously been investigated. This study aimed to compare serum AMH in mares following treatment with native porcine zona pellucida (pZP), recombinant pZP3 and pZP4 (reZP) or gonadotrophin releasing hormone (GnRH) vaccines, and saline-treated controls. Stored sera collected during two previous studies examining ovarian activity in mares during zona pellucida (ZP) or GnRH immuno...
Molecular characterization, modeling, in silico analysis of equine pituitary gonadotropin alpha subunit and docking interaction studies with ganirelix.
In silico pharmacology    July 18, 2017   Volume 5, Issue 1 5 doi: 10.1007/s40203-017-0025-1
Bhardwaj A, Nayan V, Sharma P, Kumar S, Pal Y, Singh J.Equine pituitary gonadotropins (eLH, eFSH, eCG) are heterodimeric glycoprotein hormones with alpha (α) and beta (β) subunits. It is responsible for maintenance of pregnancy in mares during early gestation and fairly valuable for inducing superovulation in animals other than equines. The alpha subunit is common, while beta subunit is species-specific in all glycoprotein hormones. In the present investigation, molecular cloning and in silico characterization including homology modeling and molecular docking analysis of the equine chorionic gonadotropin (eCG) alpha subunit was carried out for g...
Two complementary methods to control gonadotropin-releasing hormone vaccination (Improvac®) misuse in horseracing: Enzyme-linked immunosorbent assay test in plasma and steroidomics in urine.
Drug testing and analysis    June 2, 2017   Volume 9, Issue 9 1432-1440 doi: 10.1002/dta.2187
Bailly-Chouriberry L, Loup B, Popot MA, Dreau ML, Garcia P, Bruyas JF, Bonnaire Y.Since the availability on the European market of the vaccine Improvac® dedicated to male pig immunological castration, the risk of misuse of this product in horses is now considered as a threat for the horseracing industry. Immunological castration is not allowed by the racing codes (immune system, Article 6). Indeed, this vaccination against the hypothalamic hormone luteinizing hormone-releasing hormone or gonadotropin-releasing hormone (GnRH) will prevent the release from the anterior pituitary of luteinizing hormone and follicle stimulating hormone, which are required for the development a...
Effects of a single use of the GnRH analog buserelin on the induction of ovulation and endocrine profiles in heavy draft mares.
Journal of equine science    December 15, 2016   Volume 27, Issue 4 149-156 doi: 10.1294/jes.27.149
Miki W, Oniyama H, Takeda N, Kimura Y, Haneda S, Matsui M, Taya K, Nambo Y.We observed structural changes in the follicles and uterus of heavy draft mares during estrus and examined the effect of a single injection of the gonadotropin-releasing hormone analog buserelin on ovulation and endocrine profiles. Twenty-two heavy draft mares were divided into a buserelin-treated group (n=8) and a control group (n=14). Mares were given an intramuscular injection of 40 µg buserelin when they presented signs of estrus to a teaser stallion, had ≥45 mm diameter follicles, and presented decreased uterine edema compared with the previous examination. The follicles and uterus wer...
Effect of GnRH and hCG on progesterone concentration and ovarian and luteal blood flow in diestrous mares.
Animal reproduction science    November 23, 2016   Volume 176 64-69 doi: 10.1016/j.anireprosci.2016.11.010
Brito LF, Baldrighi JM, Wolf CA, Ginther OJ.The objective of the present study was to investigate the effect of reproductive hormones (GnRH, hCG, LH and progesterone) on the regulation of corpus luteum (CL) and ovarian blood flow. Diestrous mares received a single treatment of saline, 100μg gonadorelin (GnRH), or 1500IU hCG 10days after ovulation. Plasma LH and progesterone concentrations, resistance index (RI) for ovarian artery blood-flow, and percentage of corpus luteum (CL) with color-Doppler signals of blood flow were determined immediately before treatment (hour 0) and at hours 0.25, 0.5, 1, 1.5, 2, 3, 4, 5, and 6. In the GnRH gr...
Comparative efficacy of BioRelease Deslorelin® injection for induction of ovulation in oestrus mares: a field study.
Australian veterinary journal    August 30, 2016   Volume 94, Issue 9 338-340 doi: 10.1111/avj.12478
Finan SA, Lamkin EL, McKinnon AO.To investigate the comparative efficacy of BioRelease Deslorelin® (BRD) and Ovuplant® for induction of ovulation in cyclic mares in Australia. Methods: Ovarian follicular activity of 60 mares for a total of 95 cycles was monitored by ultrasonography until they developed a follicle ≥30 mm and a uterine oedema pattern of 3. Mares were then randomly allocated to one of three treatment groups: (1) treatment with 1.25 mg BRD, (2) a single Ovuplant pellet or (3) 1 mL compound sodium lactate control. Follicular activity was monitored with ultrasonography every 12 h until ovulation was detec...
Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist.
Theriogenology    July 26, 2016   Volume 86, Issue 9 2272-2280 doi: 10.1016/j.theriogenology.2016.07.021
Davolli GM, Ball BA, Esteller-Vico A, Claes AN, Canisso IF, Fedorka CE, Woodward EM, Troedsson MH, Squires EL.The GnRH antagonist, acyline, has not yet been investigated in the stallion. Our study aimed to: (1) evaluate the downregulation of the stallion hypothalamic-pituitary-gonadal axis by acyline through assessment of seminal parameters, testicular volume, and sexual behavior; (2) assess hormonal response of acyline-treated stallions to GnRH stimulation; and (3) verify reversibility after treatment. Stallions were assessed pretreatment and subsequently treated (every five days) for 50 days: acyline (n = 4; 330 μg/kg acyline) or control (n = 4, vehicle). The stallions were then monitored for 62Â...
Kisspeptin stimulates LH secretion but not ovulation in mares during vernal transition.
Theriogenology    May 25, 2016   Volume 86, Issue 6 1566-1572 doi: 10.1016/j.theriogenology.2016.05.016
McGrath BM, Scott CJ, Wynn PC, Loy J, Norman ST.Managing the return to regular cyclicity after the winter anestrous period in the mare has been a challenge for the equine breeding industry. Specifically, efforts have been made to shift or shorten the vernal transition period and to have it followed by a predictable first ovulation at the commencement of the breeding season. Intravenous administration of kisspeptin is known to stimulate an LH response in both reproductively active and inactive mares. This study examined the effects of a constant rate infusion (CRI) of kisspeptin on mares during vernal transition. Mares were given a 30 hours...
Aptamer based peptide enrichment for quantitative analysis of gonadotropin-releasing hormone by LC-MS/MS.
Talanta    January 7, 2016   Volume 150 671-680 doi: 10.1016/j.talanta.2016.01.006
Richards SL, Cawley AT, Cavicchioli R, Suann CJ, Pickford R, Raftery MJ.Over recent years threats to racing have expanded to include naturally occurring biological molecules, such as peptides and proteins, and their synthetic analogues. Traditionally, antibodies have been used to enable detection of these compounds as they allow purification and concentration of the analyte of interest. The rapid expansion of peptide-based therapeutics necessitates a similarly rapid development of suitable antibodies or other means of enrichment. Potential alternative enrichment strategies include the use of aptamers, which offer the significant advantage of chemical synthesis onc...
Concentrations of progesterone, a metabolite of PGF2α, prolactin, and luteinizing hormone during development of idiopathic persistent corpus luteum in mares.
Domestic animal endocrinology    December 28, 2015   Volume 55 114-122 doi: 10.1016/j.domaniend.2015.12.004
Ginther OJ, Baldrighi JM, Castro T, Wolf CA, Santos VG.In experiment 1, daily blood samples were available from Days 0 to 20 (Day 0 = ovulation) in mares with an interovulatory interval (IOI, n = 5) and in mares that developed idiopathic persistent corpus luteum (PCL, n = 5). The PCL was confirmed by maintenance of progesterone (P4) concentration until end of the experiment (Day 20). Significant interactions of group and day revealed the novel findings that luteinizing hormone (LH) was lower (P < 0.05) in the PCL group than that in the IOI group on Days 0 to 4, and prolactin was lower (P < 0.05) on Days 1, 4, 6, and 7. In experiment 2, treat...
Stimulation of LH, FSH, and luteal blood flow by GnRH during the luteal phase in mares.
Theriogenology    October 19, 2015   Volume 85, Issue 4 740-746 doi: 10.1016/j.theriogenology.2015.10.019
Castro T, Oliveira FA, Siddiqui MA, Baldrighi JM, Wolf CA, Ginther OJ.A study was performed on the effect of a single dose per mare of 0 (n = 9), 100 (n = 8), or 300 (n = 9) of GnRH on Day 10 (Day 0 = ovulation) on concentrations of LH, FSH, and progesterone (P4) and blood flow to the CL ovary. Hormone concentration and blood flow measurements were performed at hours 0 (hour of treatment), 0.25, 0.5, 1, 2, 3, 4, and 6. Blood flow was assessed by spectral Doppler ultrasonography for resistance to blood flow in an ovarian artery before entry into the CL ovary. The percentage of the CL with color Doppler signals of blood flow was estimated from videotapes of real-t...
Treatment with human chorionic gonadotrophin before ovulation increases progestin concentration in early equine pregnancies.
Animal reproduction science    July 11, 2014   Volume 149, Issue 3-4 187-193 doi: 10.1016/j.anireprosci.2014.07.002
Köhne M, Kuhl J, Ille N, Erber R, Aurich C.For prevention of early conceptus loss in the horse, treatment with progestins has become common practice. In cattle, treatment with human chorionic gonadotrophin (hCG) during the early postovulatory phase stimulates endogenous progesterone synthesis, which is an important factor for maintenance of early pregnancy via stimulation of endometrial function and conceptus development. In the present study we have therefore investigated the influence of treatment with hCG either for induction of ovulation or during the early luteal phase on plasma progestin concentrations, size of the corpus luteum ...
Acute injection and chronic perfusion of kisspeptin elicit gonadotropins release but fail to trigger ovulation in the mare.
Biology of reproduction    February 20, 2014   Volume 90, Issue 2 36 doi: 10.1095/biolreprod.113.114157
Decourt C, Caraty A, Briant C, Guillaume D, Lomet D, Chesneau D, Lardic L, Duchamp G, Reigner F, Monget P, Dufourny L, Beltramo M, Dardente H.Kisspeptin has emerged as the most potent gonadotropin-releasing hormone (GnRH) secretagogue and appears to represent the penultimate step in the central control of reproduction. In the sheep, we showed that kisspeptin could be used to manipulate gonadotropin secretion and control ovulation. Prompted by these results, we decided to investigate whether kisspeptin could be used as an ovulation-inducing agent in another photoperiodic domestic mammal, the horse. Equine kisspeptin-10 (eKp10) was administered intravenously as bolus injections or short- to long-term perfusions to Welsh pony mares, ei...
Hypothalamic distribution, adenohypophyseal receptor expression, and ligand functionality of RFamide-related peptide 3 in the mare during the breeding and nonbreeding seasons.
Biology of reproduction    February 13, 2014   Volume 90, Issue 2 28 doi: 10.1095/biolreprod.113.112185
Thorson JF, Prezotto LD, Cardoso RC, Sharpton SM, Edwards JF, Welsh TH, Riggs PK, Caraty A, Amstalden M, Williams GL.RFamide-related peptide 3 (RFRP3), the mammalian homologue of avian gonadotropin-inhibitory hormone, has been shown to negatively regulate the secretion of LH and may contribute to reproductive seasonality in some species. Herein, we examined the presence and potential role of the RFRP3-signaling system in regulating LH secretion in the mare during the breeding and nonbreeding seasons. Hypothalamic NPVF mRNA (the precursor mRNA for RFRP3) was detected at the level of the dorsomedial nucleus and paraventricular nucleus, but expression did not change with season. A greater number of RFRP3-expres...
Pharmacologic application of native GnRH in the winter anovulatory mare, I: frequency of reversion to the anovulatory state following ovulation induction and cessation of treatment.
Theriogenology    December 8, 2013   Volume 81, Issue 4 579-586 doi: 10.1016/j.theriogenology.2013.11.018
Thorson JF, Allen CC, Amstalden M, Williams GL.The continuous, subcutaneous infusion of native GnRH into seasonally anovulatory mares stimulates the synthesis and secretion of LH without pituitary refractoriness, offering opportunities to markedly accelerate the timing of ovulation within the operational breeding season. Herein, we tested the hypothesis that ovarian cycles induced in winter anovulatory mares using continuous administration of native GnRH for 28 days, beginning in either early February or early March (North America) would not revert to an anovulatory state after treatment withdrawal. Anovulatory mares received sham pumps (c...
Pharmacologic application of native GnRH in the winter anovulatory mare, II: accelerating the timing of pregnancy.
Theriogenology    December 8, 2013   Volume 81, Issue 4 625-631 doi: 10.1016/j.theriogenology.2013.11.017
Thorson JF, Prezotto LD, Cardoso RC, Allen CC, Alves BR, Amstalden M, Williams GL.Onset of the winter anovulatory period in mares is associated with a marked diminution in adenohypophyseal synthesis and release of LH. Native GnRH, unlike its synthetic agonists, stimulates the synthesis and secretion of LH in mares without pituitary refractoriness. Herein we tested the hypotheses that (1) the average Julian day of pregnancy can be accelerated by up to 2 months in winter anovulatory mares treated continuously with native GnRH beginning on February 1 and (2) mares will sustain luteal function and pregnancy after treatment withdrawal. Forty-two winter anovulatory mares were str...
Effects of a commercial canine gonadotropin releasing hormone vaccine on estrus suppression and estrous behavior in mares.
Animal reproduction science    September 12, 2013   Volume 142, Issue 1-2 42-47 doi: 10.1016/j.anireprosci.2013.09.002
Donovan CE, Hazzard T, Schmidt A, LeMieux J, Hathaway F, Kutzler MA.We investigated the effect of immunization against gonadotropin releasing hormone (GnRH) using a commercial canine GnRH vaccine on estrus suppression and unwanted estrous behavior in mares. In experiment 1, mares were immunized (n = 6) twice with vaccine (5 mL) given intramuscularly 4 weeks apart or received a control diluent (n = 5). Transrectal ultrasonographic examination of the reproductive tracts was performed three days a week for 40 weeks after initial vaccination. Blood samples were collected weekly for GnRH antibody titer and progesterone concentration determination. In experiment 2, ...
The effects of kisspeptin on gonadotropin release in non-human mammals.
Advances in experimental medicine and biology    April 4, 2013   Volume 784 63-87 doi: 10.1007/978-1-4614-6199-9_4
Abbara A, Ratnasabapathy R, Jayasena CN, Dhillo WS.The Kiss1 gene encodes a 145-amino acid pre-peptide, kisspeptin, which is cleaved into smaller peptides of 54, 14, 13, and 10 amino acids. This chapter reviews in detail the effects of kisspeptin on gonadotropin secretion in non-human mammals. Studies of kisspeptin's effects have included both acute and chronic administration regimens via a number of administration routes. Acute kisspeptin stimulates gonadotropin secretion in a wide range of species of non-human mammals, including rats, mice, hamsters, sheep, pigs, goats, cows, horses, and monkeys. In general, the stimulatory effect of kisspep...
Kisspeptin as a master player in the central control of reproduction in mammals: an overview of kisspeptin research in domestic animals.
Animal science journal = Nihon chikusan Gakkaiho    March 27, 2013   Volume 84, Issue 5 369-381 doi: 10.1111/asj.12056
Okamura H, Yamamura T, Wakabayashi Y.The hypothalamo-pituitary-gonadal (HPG) axis is the regulatory system for reproduction in mammals. Because secretion of gonadotropin-releasing hormone (GnRH) into the portal vessels is the final step at which the brain controls gonadal activities, the GnRH neuronal system had been thought to be central to the HPG axis. A newly discovered neural peptide, kisspeptin, has opened a new era in reproductive neuroendocrinology. As shown in a variety of mammals, kisspeptin is a potent endogenous secretagogue of GnRH, and the kisspeptin neuronal system governs both the pulsatile GnRH secretion that dri...
Reversibility of the effects of GnRH-vaccination used to suppress reproductive function in mares.
Equine veterinary journal    May 6, 2012   Volume 45, Issue 1 111-113 doi: 10.1111/j.2042-3306.2012.00577.x
Schulman ML, Botha AE, Muenscher SB, Annandale CH, Guthrie AJ, Bertschinger HJ.Active immunisation against gonadotrophin-releasing hormone (GnRH) provides a reversible method for control of oestrous behaviour and fertility in mares. Previous reports failed to demonstrate the interval to resumption of cyclic ovarian activity after GnRH-vaccination. Objective: Administration of the GnRH-vaccine Improvac in a large group of mares of various ages will result in effective, reliably reversible suppression of ovarian activity within a 2 year period. Methods: The mares, subdivided into 3 age categories, were vaccinated twice (with a 35 day interval) using 400 µg Improvac and mo...
Reproductive seasonality in the mare: neuroendocrine basis and pharmacologic control.
Domestic animal endocrinology    May 1, 2012   Volume 43, Issue 2 103-115 doi: 10.1016/j.domaniend.2012.04.001
Williams GL, Thorson JF, Prezotto LD, Velez IC, Cardoso RC, Amstalden M.Reproductive seasonality in the mare is characterized by a marked decline in adenohypophyseal synthesis and secretion of LH beginning near the autumnal equinox. Thus, ovarian cycles have ceased in most mares by the time of the winter solstice. Endogenous reproductive rhythms in seasonal species are entrained or synchronized as a result of periodic environmental cues. In the horse, this cue is primarily day length. Hence, supplemental lighting schemes have been used managerially for decades to modify the annual timing of reproduction in the mare. Although a full characterization of the cellular...
Kisspeptins and the reproductive axis: potential applications to manage reproduction in farm animals.
Domestic animal endocrinology    April 10, 2012   Volume 43, Issue 2 95-102 doi: 10.1016/j.domaniend.2012.03.002
Caraty A, Decourt C, Briant C, Beltramo M.Kisspeptins (Kp) are a family of neuropeptides produced mainly by two hypothalamic neuronal cell populations. They have recently emerged as a major regulator of the gonadotropin axis and their action is located upstream of the gonadotropin-releasing hormone (GnRH) cell population. In less than 10 yr a growing body of literature has demonstrated the involvement of these peptides in most, if not all, aspects of reproductive axis maturation and function. In contrast to these abundant basic research studies, few experiments have evaluated the potential application of Kp as tools to manipulate repr...
Secretion of luteinizing hormone into pituitary venous effluent of the follicular and luteal phase mare: novel acceleration of episodic release during constant infusion of gonadotropin-releasing hormone.
Domestic animal endocrinology    January 27, 2012   Volume 42, Issue 3 121-128 doi: 10.1016/j.domaniend.2012.01.004
Velez IC, Pack JD, Porter MB, Sharp DC, Amstalden M, Williams GL.We tested the hypothesis that continuous infusion of native GnRH into mares during the estrous cycle, at a dose of 100 μg/h, would elevate circulating concentrations of LH without disrupting the endogenous, episodic pattern of LH release. Ten cyclic mares were assigned to one of two groups (n = 5/group): (1) Control (saline) and (2) GnRH in saline (100 μg/h). On experimental day 0 (3 to 6 d after ovulation), osmotic pumps containing saline or GnRH were placed subcutaneously and connected to a jugular infusion catheter. Blood samples were collected from jugular catheters daily and at 5-min in...
Administration of a gonadotropin-releasing hormone antagonist to mares at different times during the luteal phase of the estrous cycle.
Animal reproduction science    August 16, 2011   Volume 127, Issue 3-4 188-196 doi: 10.1016/j.anireprosci.2011.07.020
Evans MJ, Alexander SL, Irvine CH, Kitson NE, Taylor TB.The GnRH antagonist cetrorelix was given during the early (Days 1-5), mid (Days 6-10 or 5-12) or for the entire (Days 1-16) luteal phase of mares to inhibit the secretion of FSH and LH (Day 0=ovulation). Frequent blood sampling from Day 6 to Day 14 was used to determine the precise time-course of the suppression (cetrorelix given Days 6-10). Cetrorelix treatment caused a decrease in FSH and LH concentrations by 8 and 16 h, respectively, and an obliteration of the response to exogenous GnRH given 24h after treatment onset. Treatment never suppressed gonadotropin concentrations to undetectable l...
Contraceptive vaccines for wildlife: a review.
American journal of reproductive immunology (New York, N.Y. : 1989)    April 19, 2011   Volume 66, Issue 1 40-50 doi: 10.1111/j.1600-0897.2011.01003.x
Kirkpatrick JF, Lyda RO, Frank KM.Wildlife, free-ranging and captive, poses and causes serious population problems not unlike those encountered with human overpopulation. Traditional lethal control programs, however, are not always legal, wise, safe, or publicly acceptable; thus, alternative approaches are necessary. Immunocontraception of free-ranging wildlife has reached the management level, with success across a large variety of species. Thus far, the immunocontraceptive research and management applications emphasis have been centered on porcine zona pellucida and gonadotropin-releasing hormone vaccines. Contraceptive succ...
Use of a gonadotrophin-releasing hormone vaccine in headshaking horses.
The Veterinary record    December 17, 2010   Volume 168, Issue 1 19 doi: 10.1136/vr.c5992
Pickles KJ, Berger J, Davies R, Roser J, Madigan JE.The aim of this study was to investigate the use of a gonadotrophin-releasing hormone (GnRH) vaccine in the treatment of headshaking in horses. Fifteen geldings received two doses of the GnRH vaccine four weeks apart. Serum was collected before and after vaccination to measure concentrations of luteinising hormone (LH) (10 horses) and follicle-stimulating hormone (FSH) (six horses). Owners recorded the frequency of seven common headshaking behaviours using a visual analogue scale (VAS) before vaccination and at two, four, eight, 12, 16 and 20 weeks after vaccination. Serum LH (P=0.008) and FSH...
An XY agonadal Oldenburg warmblood horse exhibiting a male phenotype. Kuiper H, Blum N, Distl O.In a 1.5-year-old Oldenburg horse, a clitoris-like structure instead of a penis was identified in the prepuce. The external genital organs did not show any abnormalities at visual inspection except that exteriorization of the penis was not possible, not even under general anesthesia. The horse's owner observed a continuous dripping of urine and a tendency to mild colics beginning 2 weeks after birth. Testosterone concentration was 0.01 ng/ml and therefore under the threshold for geldings, and the horse did not respond to the application of gonadotropin-releasing hormone (GnRH). The inner genit...
Clinical use of dopamine antagonist sulpiride to advance first ovulation in transitional mares.
Theriogenology    September 26, 2010   Volume 75, Issue 1 138-143 doi: 10.1016/j.theriogenology.2010.07.019
Panzani D, Zicchino I, Taras A, Marmorini P, Crisci A, Rota A, Camillo F.Artificial photoperiod treatment is currently the best method to hasten the first ovulation of the breeding season in winter anoestrus mares. However, this is not easy to apply in large herds of mares and, to be effective, has to be planned in the northern hemisphere in December at the latest. Pharmacological treatments have been proposed as alternatives: GnRH agonists, progesterone or its synthetic agonist Altrenogest, and dopamino-antagonists, as pherphenazine, domperidone or sulpiride. Dopamino-antagonists protocols, beginning at a given day of the year, gave controversial results in terms ...
Positive effect of FSH but not LH on early development of the dominant follicle in mares.
Reproduction, fertility, and development    August 28, 2010   Volume 22, Issue 7 1092-1099 doi: 10.1071/RD09275
Checura CM, Beg MA, Parrish JJ, Ginther OJ.The effects of FSH, LH or both on follicular growth and intrafollicular free insulin-like growth factor (IGF)-1 and oestradiol were investigated in mares after the beginning of deviation (largest follicle >/= 20 mm; Hour 0). A single treatment with a gonadotropin-releasing hormone antagonist (acyline) was given at Hour 3 to suppress the concentrations of FSH and LH. Five groups (n = 5 mares per group) were evaluated in the present study: (1) control; (2) acyline treated; (3) acyline + recombinant equine (re) FSH treated; (4) acyline + reLH treated; and (5) combined acyline + reFSH + reLH tr...
[The use of a GnRH vaccine in mares and stallions to influence undesirable behavior: a retrospective study of 31 cases].
Schweizer Archiv fur Tierheilkunde    August 5, 2010   Volume 152, Issue 8 373-377 doi: 10.1024/0036-7281/a000085
Wenzinger B, Kähn W, Bleul U.The aim of this study was to investigate the effect of a GnRH vaccine (Equity) on behavior and gonadal function in horses with unwanted behavior. The reason for the treatment was asked using a questionnaire and the findings of physical examination, rectal palpation as well as rectal ultrasonography, were recorded. The results of these examinations and the behavior of 21 mares and 10 stallions before the first and after the second administration of the GnRH vaccine were compared. In 84 % of all cases a decrease of the unwanted behavior could be observed. In the mares the ovaries were significan...